InvestorsHub Logo
icon url

opportunityknocking

10/16/09 8:08 AM

#23578 RE: Gold Seeker #23573

Gold put his foot in his mouth by asking <Ok, please cite anyone not connected with BioCurex that has said RECAF is one of the most significant findings today.>
You are discrediting the CHAIRMAN (chosen by his peers as a leader in cancer biomarkers) of the ISOBM (which is an international group of scientists that are ALL looking for new cancer biomarkers) who called recaf a "miracle protein".
When someone associates recaf with the word "miracle" I would accept that statement as embracing the findings of recaf as one the most significant findings in cancer diagnosis.
Also, let's dissect the meaning of what the Chairman of the ISOBM was referring when he called recaf a "miracle protein". A miracle is wonders performed by supernatural power as signs of some special mission or gift and explicitly ascribed to God.......... A GIFT FROM GOD. Is that not a significant finding in modern medicine? Why can't you embrace this gift? It could save your life or someone close to you. It is sad what you are trying to do.
icon url

Gold Seeker

10/16/09 8:41 AM

#23580 RE: Gold Seeker #23573

To have RECAF used to detect cancer would be in direct opposition to the position taken by those like Dr. Kramer. This guy is just one of many that is now saying that detecting all kinds of cancer is not good. Screening needs to only detect cancers that will harm you. Times have changed and Moro is behind the times. Cancer detection is moving another direction.


Cancer Screening
BY BARNETT S. KRAMER, MD

Intuition seems to dictate that any test capable of detecting cancer early, before the onset of symptoms, must be of benefit. Unfortunately, that intuition is wrong. More importantly, it can lead to serious harm.

Who is Dr. Kramer?

Barnett S. Kramer, M.D., editor-in-chief of the Journal of the National Cancer Institute, has been appointed director of the Office of Medical Applications of Research at the National Institutes of Health.

http://www.curetoday.com/index.cfm/fuseaction/article.show/id/2/article_id/1243
icon url

gaboy47

10/16/09 9:38 AM

#23583 RE: Gold Seeker #23573

<Half, below is the reason RECAF will never be successful. In the past few years, times have changed and screening tests like RECAF are no longer desired by the medical community. You wonder why Abbott dropped RECAF? READ the whole article.>

Gold,

How do you know where Abbott stands relative to Recaf. Could you please give the board the name and number of the Abbott employee you spoke with that told you Abbott terminated all interest in Recaf because they believe with 100% certainty there is no market for Recaf. Whether it be for diagnostic, monitoring, imaging, therapy or any other application Dr. Moro might be pursuing. If that were the case I'm 100% positive Abbott would return their license. Why hang onto a license that has no future value. No market, no need to hang on to the license, wouldn't you agree. I'm sorry but Abbott's actions contradict YOUR OPINION.

If you didn't constantly slam this company and everything associated with it, I might beleive some of your post, unfortunately because of your past history you have no credibilty with me. Most of your post are not balanced, one sided and many have repeately been proven wrong ie., the latest financing secured which you claimed would not happen. Makes one wonder what else you are wrong about. You have a bad habbit of posting pieces of articles that support your opinion and anyone that disagrees with your opinion is either naive or an idiot. Could you tell us one day which hedge fund you work for. They hire retired folks too, especially the people that have the knowledge you have about the market.

JMHO

JMHO
icon url

opportunityknocking

10/16/09 10:18 AM

#23592 RE: Gold Seeker #23573

You picked someone that thinks like you and has no regard for life or suffering. Listen to this from your brilliant Dr Kramer: "the lifetime risk of dying of prostate cancer is just over 3 percent. This means about 97 percent of men will not die of prostate cancer; but they can be harmed by screening and subsequent unnecessary therapy. Likewise, about 1 percent of women will die of ovarian cancer and 99 percent will not, irrespective of screening."
Wow!!!! I could give you reasons why the war should continue according to this guy. If statistically we only lost 9,000,000 children or young adults who cares? It is only 3% of the population. You picked a perfect match to prove how ridiculous your effort to diminish the importance of life is to you. Keep the quotes coming. You are only sounding more absurd by the minute. What a joke.
icon url

opportunityknocking

10/16/09 11:05 AM

#23599 RE: Gold Seeker #23573

Funny. You think I'm Wittenberg? Why? Because you can't believe someone that is a doctor can speak highly about what Dr Moro has discovered and accomplished? If I'm a dentist then you write science fiction novels. Don't speak or assume you know something about someone or something you certainly do not!!!
Now you want to quote doctors or use information that you feel compelled to make a now insignificant argument, and is just proving the point that you would and will cotinue to try and diminish the importance of the latest discovery about recaf that was reported at the 2009 ISOBM only a few weeks ago. Recaf used in conjunction with the PSA will give ZERO FALSE POSITIVES. I want you to explain why this recent news that is literally only a few weeks old has not changed your entire argument. You absolutely HAVE cancer. NO chance of not being malignant. And you know that it is prostrate cancer. What else do want? It will be malpractice NOT to use recaf. Tell that to the jury when you are sued. That is IMO the most significant reason that recaf IS RELEVANT and will be accepted worldwide, not to mention the point of care with Inverness and the Oncopet which has huge market potential. You sir now have the burden of why it won't be successful since the case is steadily building why it will be successful. Your old arguments just don't hold water any longer. The desperation in your posts are very evident of this fact. Post away.
icon url

opportunityknocking

10/16/09 11:36 AM

#23603 RE: Gold Seeker #23573

I am an anonymous poster just the same as you. You want me to be a dentist in your mind, I am a dentist. You want me to be hedge fund manager, I am a hedge fund manager. How about a market maker? or a circus clown? Maybe I'm a Hollywood star? Maybe a rock star? What don't you understand about being a doctor that has been in practice 20 plus years that has identified cancer in my career and knows the value of recaf. Enough said!!! You want to discredit me go ahead. I only am here because like Gaboy and Half and many others, I have a financial interest in Biocurex, and I refuse to let some anonymous poster deceive potential investors. The list of doctors that see recaf as a valuable tool in cancer diagnosis is steadily growing. That is the last statement about me. It is an offense to ask posters to identify who they are. Does that ring a bell? Move on before you lose your priveleges, and boy that would be a huge disappointment.
icon url

opportunityknocking

10/16/09 11:56 AM

#23606 RE: Gold Seeker #23573

Wow Gold, the selling sure is escalating. 3200 sold today (purely to manipulate), but IMO good news is coming and those shares sold are a headfake. Beware of manipulation. That has been the theme and remains the same. Covering is about to be expensive. The longer they drag this charade out the worse they will pay. Remember the announcement that caught you off guard about the 2 new board members, well, IMO you are about to get slapped. I'll be enjoying the show. It's a beautiful day today, so I'm out of here. Please play nice.
icon url

HALF FULL GLASS

10/16/09 3:27 PM

#23614 RE: Gold Seeker #23573

Gold stated,"Half, below is the reason RECAF will never be successful."
Gold you flip flop very often.
Following are the posts where you stated just the opposite.

Your previous posts,

If someone does commercializes the test and it develops a market that results in a profitable company, then the company will be successful.


"I have no idea if it will be successful at all."

If Inverness proceeds and is successful in marketing a RECAF product, BioCurex would indeed definitely succeed also.

A question: Would that number of owners be sufficient to make RECAF successful?

If Inverness made a positive announcement, investors here would no doubt gamble that RECAF might be successful.

First of all, doctors need to accept the laboratory version of RECAF before any rapid test would be successful.

You are proof that Moro was successful to some extent.

I have stated that RECAF could probably get approved to monitor colon cancer.

Dakota, I have done extensive research into the technology
that RECAF uses and it WORKS. It will be a huge seller and IMO, look for some data to be presented at the July 24th conference in a presentation by the lead developer of the RECAF test at Abbott. Dr. Moro will go down in history as one of the leading developers of cancer detection and treatment.

The personalization aspect of the test is huge. Any developing cancer will cause your RECAF level to dramatically increase. It detects the level of cancer cell division so any change in your normal level is a RED ALERT. Researchers are developing treatments that use the same technology so it does not really matter where the cancer is.

"I have never stated that RECAF could not be used for therapeutics."

"It works like nothing else out there"

"I know the test can detect cancer cells."

"I in fact agree that studies show it does detect if cancer is present in the body."

"The test works and was proven at the ISOBM."

"I think that RECAF may get approval to monitor existing cancer "

"BTW, I have always stated that the RECAF test does indeed work."

"The test works as demonstrated at the ISOBM so IMO, there is no more tweeking necessary."

" This is actually a good idea...if everything goes as Moro states, I do think Moro will get revenue from this test. In fact, it may be his best source of revenue for the product period."